Sexual dysfunction after radical prostatectomy

Area of Science:

• Urology
• Oncology
• Sexual Medicine

Background:

• Radical retropubic prostatectomy (RRP) is a common treatment for prostate cancer.
• Sexual dysfunction is a frequent and significant side effect of RRP.
• Pre-existing sexual health issues and the stress of diagnosis can exacerbate post-surgical dysfunction.

Purpose of the Study:

• To detail the timeline and characteristics of sexual dysfunction following RRP.
• To evaluate the efficacy of phosphodiesterase (PDE)-5 inhibitors and combination therapies for post-prostatectomy sexual dysfunction.
• To identify factors influencing recovery from sexual dysfunction after RRP.

Main Methods:

• Review of existing literature on sexual dysfunction after RRP.
• Analysis of patient outcomes regarding erectile function, ejaculatory function, and orgasm quality.
• Assessment of treatment responses to PDE-5 inhibitors and alternative therapies.

Main Results:

• Sexual dysfunction, including erectile dysfunction, often begins before RRP and persists post-surgery.
• All patients experience loss of ejaculate after RRP; orgasm quality is frequently impaired.
• Erectile dysfunction is immediate, with slow recovery; PDE-5 inhibitors may require up to 18 months for maximal effect.
• Younger men undergoing bilateral nerve-sparing procedures show the best response.
• Combination therapies may offer salvage options for non-responders to initial PDE-5 inhibitor treatment.

Conclusions:

• Sexual dysfunction is an inevitable and often severe consequence of RRP.
• Nerve-sparing techniques and timely, appropriate medical interventions are crucial for managing post-RRP sexual dysfunction.
• Patient counseling regarding the timeline of recovery and treatment options is essential.